Home Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer
 

Keywords :   


Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer

2016-01-23 03:23:46| Biotech - Topix.net

's stock had its "outperform" rating restated by equities research analysts at Oppenheimer in a research report issued to clients and investors on Friday, MarketBeat reports. They currently have a $4.00 price objective on the biotechnology company's stock.

Tags: rating receives gale outperform

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.06Royal Mail buyer to make offer for all staff shares
25.06Hybrid Software wins FLAG Vendor Partner of the Year award
25.06Hospeco Purchases Nuance Solutions
25.06Atlantic Tropical Weather Outlook
25.06DNA Genetics opens new commercial sow research farm
25.06Eastern North Pacific Tropical Weather Outlook
25.06Briolf Group to Invest $30 Million in Its First US Production Plant
25.06IDENTCO rebrands TTL200 Series to DuraWrap and DuraFlag
More »